Pharmacokinetic modelling for the simultaneous assessment of perfusion and 18 F-flutemetamol uptake...
Pharmacokinetic modelling for the simultaneous assessment of perfusion and 18 F-flutemetamol uptake in cerebral amyloid angiopathy using a reduced PET-MR acquisition time: Proof of concept
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease associated with perivascular β-amyloid deposition. CAA is also associated with strokes due to lobar intracerebral haemorrhage (ICH).
F-flutemetamol amyloid ligand PET may improve the early detection of CAA. We performed pharmacokinetic modelling using both full (0-30, 90-120 mi...
Alternative Titles
Full title
Pharmacokinetic modelling for the simultaneous assessment of perfusion and 18 F-flutemetamol uptake in cerebral amyloid angiopathy using a reduced PET-MR acquisition time: Proof of concept
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2470270367
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2470270367
Other Identifiers
ISSN
1053-8119
E-ISSN
1095-9572
DOI
10.1016/j.neuroimage.2020.117482
